Genesis Global Group
Genesis Drug Discovery & Development
GD3

You will now be redirected to the GD3 website

Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3
Search

Biochemistry & Bioanalytical

LC-MS/MS

Delivering Precision and Speed: Your Drug Development Partner

Our bioanalytical services are designed to accelerate your drug discovery and development process. With a commitment to the highest quality data, we provide timely results that support informed decision-making regarding your drug candidate.

  • Our expert scientists specialize in:
    • Method Development and Validation: Tailoring analytical approaches to meet your unique compound requirements.
    • Sample Analysis: Precisely quantifying small and large molecules, metabolites, and peptides in biological matrices.
    • LC-MS/MS Expertise: Leveraging state-of-the-art SCIEX and Thermo platforms for sensitive and accurate detection of small molecule and peptide detection.

Partner with us to achieve your drug development goals efficiently and effectively.

  • Expertise with:
    • Small molecules
    • Peptides
    • Amino acids
    • Melanin binding assay
    • Formulation screening
  • Preclinical Non-Regulated Studies:
    • Formulation screening and stability assessment
    • Rapid screening bioanalytical methods
    • Method development
    • Method transfer
    • Tissue qualifications
    • Sample analysis – in vitro and in vivo PK/PD/TK
    • Statistical analysis (PK/TK)
    • Melanin binding assay
    • Small molecules, amino acids, peptides, metabolites
    • Expertise with ocular matrices
  • Regulated Studies:
    • Non-clinical and clinical
    • Method development
    • Method transfer
    • Method validation
    • Sample analysis
    • Small molecules, amino acids, peptides, metabolites
    • Following FDA GxP and OECD guidances
    • Expertise with ocular matrices
    • Statistical analysis (PK/TK)